Stockscreener 앱 받기
7.77
3.60%
0.27
Iteos Therapeutics Inc 주식(ITOS)의 최신 뉴스
Q2 EPS Forecast for iTeos Therapeutics Increased by Analyst - Defense World
(ITOS) Investment Analysis - news.stocktradersdaily.com
Wall Street Analysts See a 211.07% Upside in iTeos Therapeutics (ITOS): Can the Stock Really Move This High? - Yahoo Finance
iTeos Therapeutics (ITOS) Expected to Announce Quarterly Earnings on Friday - Defense World
Q2 EPS Estimates for iTeos Therapeutics Lowered by Wedbush - Defense World
Market Watch: ITeos Therapeutics Inc (ITOS)’s Noteworthy Gain, Closing at 7.25 - DWinneX
Chief Financial Officer Gall Matthew acquire 5,000 shares of ITeos Therapeutics Inc [ITOS] - knoxdaily.com
ITeos Therapeutics Inc (ITOS) produces promising results - uspostnews.com
iTeos Therapeutics Reports Q1 2025 Financial Results - TipRanks
iTeos meldet Finanzergebnisse für das erste Quartal 2025 und gibt aktuelle Geschäftsinformationen bekannt - GlobeNewswire Inc.
iTeos meldet Finanzergebnisse für das erste Quartal 2025 und gibt aktuelle Geschäftsinformationen bekannt - GlobeNewswire
iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates | ITOS Stock News - GuruFocus
iTeos Therapeutics (ITOS) Receives Adjusted Price Target from We - GuruFocus
iTeos Therapeutics stock rises as Q1 loss narrows, beats estimates By Investing.com - Investing.com Nigeria
iTeos (ITOS) Progresses with Promising Results from GALAXIES Lun - GuruFocus
iTeos Therapeutics stock rises as Q1 loss narrows, beats estimates - Investing.com
iTeos Therapeutics Reports Upcoming Interim Data from Multiple Clinical Trials and Financial Results for Q1 2025 - Nasdaq
iTeos Therapeutics, Inc. SEC 10-Q Report - TradingView
iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire
Analysts Say That ITeos Therapeutics Inc (NASDAQ:ITOS) Is Likely To Make It To 17 In 12 Months - Marketing Sentinel
Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 7.15, Down by -4.03 - DWinneX
Chief Financial Officer Gall Matthew acquired 5,000 shares of ITeos Therapeutics Inc [ITOS] - knoxdaily.com
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Russell Investments Group Ltd. - Defense World
Form DEFA14A iTeos Therapeutics, Inc. - StreetInsider
ITeos Therapeutics Inc (ITOS) Stock: From Low to High in 52 Weeks - investchronicle.com
There is no doubt that ITeos Therapeutics Inc (ITOS) ticks all the boxes. - Sete News
ITeos Therapeutics Inc (ITOS) stock on the rise: An overview - uspostnews.com
ITeos Therapeutics Inc [ITOS] Insider Activity: An Update for Investors - knoxdaily.com
Head-To-Head Contrast: iTeos Therapeutics (NASDAQ:ITOS) & Invizyne Technologies (NASDAQ:IZTC) - Defense World
Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year - Yahoo Finance
(ITOS) On The My Stocks Page - news.stocktradersdaily.com
Behind ITeos Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
Wellington Management Group LLP Purchases 4,563 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
American Century Companies Inc. Has $522,000 Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
KLP Kapitalforvaltning AS Acquires New Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Raymond James Financial Inc. Buys New Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges - Investing.com Australia
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Virtu Financial LLC - Defense World
Charles Schwab Investment Management Inc. Sells 22,939 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Charles Schwab Investment Management Inc. Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - The AM Reporter
Bank of New York Mellon Corp Sells 35,918 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc Stock: Cancer Drug Pipeline Shows Promise - Sharewise
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 - GlobeNewswire
Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com
Victory Capital Management Inc. Has $782,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
US Bancorp DE Acquires 4,843 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Wall Street Analysts Think iTeos Therapeutics (ITOS) Could Surge 212.5%: Read This Before Placing a Bet - Yahoo Finance
(ITOS) Investment Report - news.stocktradersdaily.com
Research Analysts Offer Predictions for ITOS Q1 Earnings - Defense World
0.47%
2.63%
자본화:
|
볼륨(24시간):